ACCU-CHEK ® PERFORMA TEST STRIPS
Report
- Report Number
- 1823260-2013-03292
- Event Type
- Malfunction
- Date Received
- May 31, 2013
- Date of Event
- May 6, 2013
- Report Date
- July 28, 2025
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- LFR
- PMA / PMN Number
- NA
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
- Health Professional
- N
Narratives
THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES. THIS MEDWATCH IS FOR THE PERFORMA COMBO SYSTEM. REFERENCE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR THE PERFORMA NANO SYSTEM. THE CUSTOMER USED ALL 3 STRIP LOTS ON BOTH SYSTEMS: LOT NUMBER: 470975 EXPIRATION 10/31/2013 LOT NUMBER: 470929 EXPIRATION 09/30/2013 LOT NUMBER: 470758 EXPIRATION 07/31/2013. RETENTION TESTING PERFORMED ON: LOT NUMBER: 470929 EXPIRATION 09/30/2013 LOT NUMBER: 470758 EXPIRATION 07/31/2013.
REPORTER STATED THAT CUSTOMER RECEIVED THE FOLLOWING RESULTS ON THE PERFORMA COMBO SYSTEM WITHIN 8 MINUTES: 30 MG/DL AND 446 MG/DL, 446 MG/DL AND 209 MG/DL RESULT OF 446 MG/DL WAS NOT DUPLICATED. RESULTS WERE OBTAINED AT DIFFERENT TIMES. REPORTER ALSO STATED THAT CUSTOMER RECEIVED THE FOLLOWING RESULTS ON 2 DIFFERENT METERS WITHIN 7 MINUTES: 430 MG/DL, 514 MG/DL, 327 MG/DL, 131 MG/DL (PERFORMA COMBO SYSTEM) 212 MG/DL (PERFORMA NANO SYSTEM) ALL READINGS OCCURRED WITH THREE DIFFERENT STRIP LOTS. CUSTOMER IS NOT SURE WHICH STRIP LOT PRODUCED WHICH RESULTS. NO ACTIONS TAKEN BASED ON DEVICE RESULTS. NO ADVERSE EVENT DUE TO THE DEVICE REPORTED. THE MANUFACTURER REQUESTED RETURN OF SUSPECT PRODUCT FOR EVALUATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 241767 | ACCU-CHEK ® PERFORMA TEST STRIPS | BLOOD GLUCOSE MONITORING TEST STRIPS | LFR | ROCHE DIAGNOSTICS | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 15 YR | Male |